Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCHW) Research & Development (2022 - 2025)

Historic Research & Development for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to $2.7 million.

  • Envoy Medical's Research & Development fell 206.75% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 333.55%. This contributed to the annual value of $10.2 million for FY2024, which is 1365.56% up from last year.
  • Envoy Medical's Research & Development amounted to $2.7 million in Q3 2025, which was down 206.75% from $2.5 million recorded in Q2 2025.
  • Envoy Medical's Research & Development's 5-year high stood at $3.1 million during Q4 2023, with a 5-year trough of $935000.0 in Q3 2022.
  • Over the past 4 years, Envoy Medical's median Research & Development value was $2.5 million (recorded in 2024), while the average stood at $2.3 million.
  • In the last 5 years, Envoy Medical's Research & Development surged by 11171.17% in 2023 and then tumbled by 1911.62% in 2024.
  • Over the past 4 years, Envoy Medical's Research & Development (Quarter) stood at $1.4 million in 2022, then skyrocketed by 111.71% to $3.1 million in 2023, then fell by 19.12% to $2.5 million in 2024, then grew by 9.27% to $2.7 million in 2025.
  • Its Research & Development stands at $2.7 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.7 million for Q1 2025.